Health care-associated transmission of hepatitis B and C in oncology care.
The risk of acquiring hepatitis B and C in the oncology setting was historically high and predominantly related to blood product administration in the prescreening era. With the development of progressively more sophisticated testing for hepatitis B and C, breaches in infection control have played an increasingly prominent role in disease transmission. Optimizing infection control in inpatient and outpatient oncology settings is essential in preventing the health care-associated transmission of hepatitis B and C to oncology patients.
Stevens
Michael P
MP
Division of Infectious Diseases, Virginia Commonwealth University Medical Center, 1201 East Marshall Street, P.O. Box 980019, Richmond, Virginia 23298-0019, USA. mstevens2@mcvh-vcu.edu
Edmond
Michael B
MB
D000553:Ambulatory Care; D003428:Cross Infection / Q000517:prevention & control / Q000635:transmission*; D006509:Hepatitis B / Q000517:prevention & control / Q000635:transmission*; D006526:Hepatitis C / Q000517:prevention & control / Q000635:transmission*; D006801:Humans; D017053:Infection Control / Q000379:methods; D008495:Medical Oncology; D016522:Oncology Service, Hospital; D012307:Risk Factors; D065227:Transfusion Reaction